ALB and cancer: Cisplatin-loaded albumin–gold nanoparticles could interact with glycans of the GP60 receptor, and the mechanisms of this interaction were explored at the molecular and cellular levels by Jaiswal et al.; thus, this finding could be effectively used for in vivo or in vitro targeted drug delivery applications to cure cancer (Jaiswal et al., 2023).